Trial Profile
Effect of Ruxolitinib in patients with Myelofibrosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Apr 2015
Price :
$35
*
At a glance
- Drugs Ruxolitinib (Primary)
- Indications Myelofibrosis
- Focus Adverse reactions
- 17 Apr 2015 New trial record